STAT5B and lymphoma: In the ENKTCL arising in East Asia, genetic analyses have shown that activating mutations of the JAK-STAT pathway, such as in JAK3 (5–35%), STAT3 (6–27%) and STAT5B (2–6%) genes are characteristic of this lymphoma [498,499].